ALZCUR — AlzeCure Pharma AB Balance Sheet
0.000.00%
- SEK229.25m
- SEK172.90m
Annual balance sheet for AlzeCure Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 112 | 41.7 | 25.6 | 29.1 | 31.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.06 | 1.54 | 1.38 | 1.47 | 1.77 |
| Prepaid Expenses | |||||
| Total Current Assets | 116 | 44.2 | 27.5 | 31.6 | 34.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.94 | 1.42 | 0.852 | 0.376 | 0.207 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 118 | 45.6 | 70.8 | 32 | 34.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.07 | 12.7 | 10.4 | 8.23 | 8.25 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 7.07 | 12.7 | 10.4 | 8.23 | 8.25 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 111 | 33 | 60.5 | 23.8 | 26.2 |
| Total Liabilities & Shareholders' Equity | 118 | 45.6 | 70.8 | 32 | 34.4 |
| Total Common Shares Outstanding |